{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:00:15Z","timestamp":1790398815735,"version":"4.1.0"},"publisher-location":"Cham","reference-count":104,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030175887","type":"print"},{"value":"9783030175894","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/5584_2018_331","type":"book-chapter","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T09:05:06Z","timestamp":1549271106000},"page":"37-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["CRISPR\/Cas9 for Sickle Cell Disease: Applications, Future Possibilities, and Challenges"],"prefix":"10.1007","author":[{"given":"Selami","family":"Demirci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Haro-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"issue":"7717","key":"331_CR1","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","volume":"560","author":"F Adikusuma","year":"2018","unstructured":"Adikusuma F, Piltz S, Corbett MA, Turvey M, McColl SR, Helbig KJ, Beard MR, Hughes J, Pomerantz RT, Thomas PQ (2018) Large deletions induced by Cas9 cleavage. Nature 560(7717):E8\u2013E9","journal-title":"Nature"},{"issue":"6","key":"331_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.molcel.2016.02.020","volume":"61","author":"C Anders","year":"2016","unstructured":"Anders C, Bargsten K, Jinek M (2016) Structural plasticity of PAM recognition by engineered variants of the RNA-guided endonuclease Cas9. Mol Cell 61(6):895\u2013902","journal-title":"Mol Cell"},{"issue":"17","key":"331_CR3","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood-2017-10-811505","volume":"131","author":"C Antoniani","year":"2018","unstructured":"Antoniani C, Meneghini V, Lattanzi A, Felix T, Romano O, Magrin E, Weber L, Pavani G, El Hoss S, Kurita R (2018) Induction of fetal hemoglobin synthesis by CRISPR\/Cas9-mediated editing of the human \u03b2-globin locus. Blood 131(17):1960\u20131973. https:\/\/doi.org\/10.1182\/blood-2017-10-811505","journal-title":"Blood"},{"issue":"11","key":"331_CR4","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3324\/haematol.2017.169581","volume":"102","author":"SD Arnold","year":"2017","unstructured":"Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z, Hall M, Atsuta Y, Dalal J, Hahn T (2017) Clinical risks and healthcare utilization of haematopoietic cell transplantation for sickle cell disease in the US using merged databases. Haematologica 102(11):1823\u20131832. https:\/\/doi.org\/10.3324\/haematol.2017.169581","journal-title":"Haematologica"},{"issue":"8","key":"331_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.tig.2018.05.004","volume":"34","author":"RO Bak","year":"2018","unstructured":"Bak RO, Gomez-Ospina N, Porteus MH (2018) Gene editing on center stage. Trends Genet 34(8):600\u2013611","journal-title":"Trends Genet"},{"issue":"6","key":"331_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ajh.21443","volume":"84","author":"SK Ballas","year":"2009","unstructured":"Ballas SK (2009) The cost of health care for patients with sickle cell disease. Am J Hematol 84(6):320\u2013322","journal-title":"Am J Hematol"},{"issue":"6155","key":"331_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1126\/science.1242088","volume":"342","author":"DE Bauer","year":"2013","unstructured":"Bauer DE, Kamran SC, Lessard S, Xu J, Fujiwara Y, Lin C, Shao Z, Canver MC, Smith EC, Pinello L (2013) An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342(6155):253\u2013257","journal-title":"Science"},{"issue":"4","key":"331_CR8","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bbmt.2014.12.007","volume":"21","author":"M Bhatia","year":"2015","unstructured":"Bhatia M, Kolva E, Cimini L, Jin Z, Satwani P, Savone M, George D, Garvin J, Paz ML, Briamonte C (2015) Health-related quality of life after allogeneic hematopoietic stem cell transplantation for sickle cell disease. Biol Blood Marrow Transplant 21(4):666\u2013672","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7577","key":"331_CR9","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature15521","volume":"527","author":"MC Canver","year":"2015","unstructured":"Canver MC, Smith EC, Sher F, Pinello L, Sanjana NE, Shalem O, Chen DD, Schupp PG, Vinjamur DS, Garcia SP (2015) BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature 527(7577):192\u2013197","journal-title":"Nature"},{"issue":"8","key":"331_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/sj.bmt.1705622","volume":"39","author":"S Chakrabarti","year":"2007","unstructured":"Chakrabarti S, Bareford D (2007) A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease. Bone Marrow Transplant 39(8):447\u2013451","journal-title":"Bone Marrow Transplant"},{"key":"331_CR11","doi-asserted-by":"publisher","unstructured":"Charlesworth CT, Deshpande PS, Dever DP, Dejene B, Gomez-Ospina N, Mantri S, Pavel-Dinu M, Camarena J, Weinberg KI, Porteus MH (2018) Identification of pre-existing adaptive immunity to Cas9 proteins in humans. BioRxiv:243345. https:\/\/doi.org\/10.1101\/243345","DOI":"10.1101\/243345"},{"key":"331_CR12","doi-asserted-by":"publisher","first-page":"eaau0766","DOI":"10.1126\/sciadv.aau0766","volume":"4","author":"P Chatterjee","year":"2018","unstructured":"Chatterjee P, Jakimo N, Jacobson JM (2018) Minimal PAM specificity of a highly similarSpCas9 ortholog. Sci Adv 4:eaau0766","journal-title":"Sci Adv"},{"issue":"7676","key":"331_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature24268","volume":"550","author":"JS Chen","year":"2017","unstructured":"Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, Sternberg SH, Joung JK, Yildiz A, Doudna JA (2017) Enhanced proofreading governs CRISPR\u2013Cas9 targeting accuracy. Nature 550(7676):407\u2013410","journal-title":"Nature"},{"key":"331_CR14","doi-asserted-by":"publisher","unstructured":"Chung JE, Magis W, Vu J, Heo S-J, Wartiovaara K, Walters MC, Kurita R, Nakamura Y, Boffelli D, Martin DI (2018) CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells. BioRxiv:335729. https:\/\/doi.org\/10.1101\/335729","DOI":"10.1101\/335729"},{"issue":"1","key":"331_CR15","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41467-018-03927-0","volume":"9","author":"CR Cromwell","year":"2018","unstructured":"Cromwell CR, Sung K, Park J, Krysler AR, Jovel J, Kim SK, Hubbard BP (2018) Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity. Nat Commun 9(1):1448","journal-title":"Nat Commun"},{"issue":"7","key":"331_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jcyt.2018.04.003","volume":"20","author":"S Demirci","year":"2018","unstructured":"Demirci S, Uchida N, Tisdale JF (2018) Gene therapy for sickle cell disease: an update. Cytotherapy 20(7):899\u2013910","journal-title":"Cytotherapy"},{"issue":"7629","key":"331_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature20134","volume":"539","author":"DP Dever","year":"2016","unstructured":"Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, Pavel-Dinu M, Saxena N, Wilkens AB, Mantri S (2016) CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells. Nature 539(7629):384\u2013389","journal-title":"Nature"},{"issue":"360","key":"331_CR18","doi-asserted-by":"publisher","first-page":"360ra134","DOI":"10.1126\/scitranslmed.aaf9336","volume":"8","author":"MA DeWitt","year":"2016","unstructured":"DeWitt MA, Magis W, Bray NL, Wang T, Berman JR, Urbinati F, Heo S-J, Mitros T, Mu\u00f1oz DP, Boffelli D (2016) Selection-free genome editing of the sickle mutation in human adult hematopoietic stem\/progenitor cells. Science Transl Med 8(360):360ra134\u2013360ra134","journal-title":"Science Transl Med"},{"issue":"8","key":"331_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1053\/j.seminhematol.2018.04.014","volume":"55","author":"EB Esrick","year":"2018","unstructured":"Esrick EB, Bauer DE (2018) Genetic therapies for sickle cell disease. Semin Hematol 55(8):76\u201386","journal-title":"Semin Hematol"},{"key":"331_CR20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood-2018-99-116733","volume":"132","author":"EB Esrick","year":"2018","unstructured":"Esrick EB, Brendel C, Manis JP, Armant MA, Negre H, Dansereau C, Ciuculescu MF, Patriarca S, Mackinnon B, Daley H (2018) Flipping the switch: initial results of genetic targeting of the fetal to adult globin switch in sickle cell patients. Blood 132:1023","journal-title":"Blood"},{"issue":"4","key":"331_CR21","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.203018","volume":"131","author":"AF Ferreira","year":"2018","unstructured":"Ferreira AF, Calin GA, Pican\u00e7o-Castro V, Kashima S, Covas DT, de Castro FA (2018) Hematopoietic stem cells from induced pluripotent stem cells\u2013considering the role of microRNA as a cell differentiation regulator. J Cell Sci 131(4):jcs203018","journal-title":"J Cell Sci"},{"issue":"4","key":"331_CR22","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1093\/nar\/gkt1074","volume":"42","author":"I Fonfara","year":"2013","unstructured":"Fonfara I, Le Rhun A, Chylinski K, Makarova KS, Lecrivain A-L, Bzdrenga J, Koonin EV, Charpentier E (2013) Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res 42(4):2577\u20132590","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"331_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1749-6632.1998.tb10460.x","volume":"850","author":"BG Forget","year":"1998","unstructured":"Forget BG (1998) Molecular basis of hereditary persistence of fetal hemoglobin. Ann N Y Acad Sci 850(1):38\u201344","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"331_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31(9):822\u2013826","journal-title":"Nat Biotechnol"},{"issue":"3","key":"331_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nbt.2808","volume":"32","author":"Y Fu","year":"2014","unstructured":"Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK (2014) Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32(3):279\u2013284","journal-title":"Nat Biotechnol"},{"issue":"6","key":"331_CR26","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/stem.2335","volume":"34","author":"A Fujita","year":"2016","unstructured":"Fujita A, Uchida N, Haro-Mora JJ, Winkler T, Tisdale J (2016) \u03b2-globin-expressing definitive erythroid progenitor cells generated from embryonic and induced pluripotent stem cell-derived sacs. Stem Cells 34(6):1541\u20131552","journal-title":"Stem Cells"},{"issue":"2","key":"331_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.tibtech.2017.11.006","volume":"36","author":"Z Glass","year":"2018","unstructured":"Glass Z, Lee M, Li Y, Xu Q (2018) Engineering the delivery system for CRISPR-based genome editing. Trends Biotechnol 36(2):173\u2013185","journal-title":"Trends Biotechnol"},{"issue":"11","key":"331_CR28","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","volume":"129","author":"E Gluckman","year":"2017","unstructured":"Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Sim\u00f5es BP, Ferster A, Dupont S, De La Fuente J (2017) Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood 129(11):1548\u20131556","journal-title":"Blood"},{"issue":"6399","key":"331_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1126\/science.aao0932","volume":"361","author":"JD Grevet","year":"2018","unstructured":"Grevet JD, Lan X, Hamagami N, Edwards CR, Sankaranarayanan L, Ji X, Bhardwaj SK, Face CJ, Posocco DF, Abdulmalik O (2018) Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells. Science 361(6399):285\u2013290","journal-title":"Science"},{"issue":"9","key":"331_CR30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nbt.3290","volume":"33","author":"A Hendel","year":"2015","unstructured":"Hendel A, Bak RO, Clark JT, Kennedy AB, Ryan DE, Roy S, Steinfeld I, Lunstad BD, Kaiser RJ, Wilkens AB (2015) Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol 33(9):985\u2013989. https:\/\/doi.org\/10.1038\/nbt.3290","journal-title":"Nat Biotechnol"},{"issue":"6","key":"331_CR31","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.molcel.2016.02.018","volume":"61","author":"S Hirano","year":"2016","unstructured":"Hirano S, Nishimasu H, Ishitani R, Nureki O (2016) Structural basis for the altered PAM specificities of engineered CRISPR-Cas9. Mol Cell 61(6):886\u2013894","journal-title":"Mol Cell"},{"issue":"9","key":"331_CR32","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/mt.2016.148","volume":"24","author":"MD Hoban","year":"2016","unstructured":"Hoban MD, Lumaquin D, Kuo CY, Romero Z, Long J, Ho M, Young CS, Mojadidi M, Fitz-Gibbon S, Cooper AR (2016a) CRISPR\/Cas9-mediated correction of the sickle mutation in human CD34+ cells. Mol Ther 24(9):1561\u20131569","journal-title":"Mol Ther"},{"issue":"7","key":"331_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1182\/blood-2015-09-618587","volume":"127","author":"MD Hoban","year":"2016","unstructured":"Hoban MD, Orkin SH, Bauer DE (2016b) Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease. Blood 127(7):839\u2013848","journal-title":"Blood"},{"issue":"1","key":"331_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jama.2014.7192","volume":"312","author":"MM Hsieh","year":"2014","unstructured":"Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, Rodgers GP, Powell JD, Tisdale JF (2014) Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA 312(1):48\u201356","journal-title":"JAMA"},{"issue":"7699","key":"331_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","volume":"556","author":"JH Hu","year":"2018","unstructured":"Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, Zeina CM, Gao X, Rees HA, Lin Z (2018) Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556(7699):57\u201363","journal-title":"Nature"},{"issue":"5","key":"331_CR36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/stem.1969","volume":"33","author":"X Huang","year":"2015","unstructured":"Huang X, Wang Y, Yan W, Smith C, Ye Z, Wang J, Gao Y, Mendelsohn L, Cheng L (2015) Production of gene-corrected adult beta globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation. Stem Cells 33(5):1470\u20131479","journal-title":"Stem Cells"},{"key":"331_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.omtm.2017.11.005","volume":"8","author":"O Humbert","year":"2018","unstructured":"Humbert O, Peterson CW, Norgaard ZK, Radtke S, Kiem H-P (2018) A nonhuman primate transplantation model to evaluate hematopoietic stem cell gene editing strategies for \u03b2-hemoglobinopathies. Mol Ther Methods Clin Dev 8:75\u201386","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"331_CR38","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/cr.2017.16","volume":"27","author":"C Jiang","year":"2017","unstructured":"Jiang C, Mei M, Li B, Zhu X, Zu W, Tian Y, Wang Q, Guo Y, Dong Y, Tan X (2017) A non-viral CRISPR\/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo. Cell Res 27(3):440\u2013443","journal-title":"Cell Res"},{"issue":"6096","key":"331_CR39","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816\u2013821. https:\/\/doi.org\/10.1126\/science.1225829","journal-title":"Science"},{"issue":"4","key":"331_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nbt.3803","volume":"35","author":"YB Kim","year":"2017","unstructured":"Kim YB, Komor AC, Levy JM, Packer MS, Zhao KT, Liu DR (2017) Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat Biotechnol 35(4):371\u2013376","journal-title":"Nat Biotechnol"},{"key":"331_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1101\/gr.231936.117","volume":"28","author":"S Kim","year":"2018","unstructured":"Kim S, Koo T, Jee H-G, Cho H-Y, Lee G, Lim D-G, Shin HS, Kim J-S (2018) CRISPR RNAs trigger innate immune responses in human cells. Genome Res 28:367\u2013373. https:\/\/doi.org\/10.1101\/gr.231936.117","journal-title":"Genome Res"},{"issue":"7561","key":"331_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales AP, Li Z, Peterson RT, Yeh J-RJ (2015a) Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523(7561):481\u2013485","journal-title":"Nature"},{"issue":"12","key":"331_CR43","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nbt.3404","volume":"33","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver BP, Prew MS, Tsai SQ, Nguyen NT, Topkar VV, Zheng Z, Joung JK (2015b) Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol 33(12):1293\u20131298","journal-title":"Nat Biotechnol"},{"issue":"7587","key":"331_CR44","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK (2016) High-fidelity CRISPR\u2013Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529(7587):490\u2013495","journal-title":"Nature"},{"issue":"8","key":"331_CR45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki M, Tomberg K, Bradley A (2018) Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol 36(8):765\u2013771","journal-title":"Nat Biotechnol"},{"key":"331_CR46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1182\/blood-2018-99-119518","volume":"132","author":"X Lan","year":"2018","unstructured":"Lan X, Khandros E, Grevet JD, Peslak SA, Bhardwaj S, Keller CA, Giardine B, Garcia BA, Hardison RC, Shi J (2018) Domain-focused CRISPR-Cas9 screen identifies the E3 ubiquitin ligase substrate adaptor protein SPOP as a novel repressor of fetal hemoglobin. Blood 132:414","journal-title":"Blood"},{"issue":"2","key":"331_CR47","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/003335491312800206","volume":"128","author":"S Lanzkron","year":"2013","unstructured":"Lanzkron S, Carroll CP, Haywood C Jr (2013) Mortality rates and age at death from sickle cell disease: US, 1979\u20132005. Public Health Rep 128(2):110\u2013116","journal-title":"Public Health Rep"},{"issue":"1","key":"331_CR48","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/s41467-018-05477-x","volume":"9","author":"JK Lee","year":"2018","unstructured":"Lee JK, Jeong E, Lee J, Jung M, Shin E, Kim Y-h, Lee K, Jung I, Kim D, Kim S (2018) Directed evolution of CRISPR-Cas9 to increase its specificity. Nat Commun 9(1):3048","journal-title":"Nat Commun"},{"issue":"2","key":"331_CR49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jmb.2016.11.024","volume":"429","author":"RT Leenay","year":"2017","unstructured":"Leenay RT, Beisel CL (2017) Deciphering, communicating, and engineering the CRISPR PAM. J Mol Biol 429(2):177\u2013191","journal-title":"J Mol Biol"},{"issue":"9","key":"331_CR50","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1182\/blood-2002-04-1104","volume":"100","author":"Q Li","year":"2002","unstructured":"Li Q, Peterson KR, Fang X, Stamatoyannopoulos G (2002) Locus control regions. Blood 100(9):3077\u20133086","journal-title":"Blood"},{"key":"331_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep30422","volume":"6","author":"C Li","year":"2016","unstructured":"Li C, Ding L, Sun C-W, Wu L-C, Zhou D, Pawlik KM, Khodadadi-Jamayran A, Westin E, Goldman FD, Townes TM (2016) Novel HDAd\/EBV reprogramming vector and highly efficient Ad\/CRISPR-Cas sickle cell disease gene correction. Sci Rep 6:30422","journal-title":"Sci Rep"},{"key":"331_CR52","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1182\/blood-2018-03-838540","volume":"131","author":"C Li","year":"2018","unstructured":"Li C, Psatha N, Sova P, Gil S, Wang H, Kim J, Kulkarni C, Valensisi C, Hawkins RD, Stamatoyannopoulos G (2018) Reactivation of \u03b3-globin in adult \u03b2-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing. Blood 131:2915\u20132928. https:\/\/doi.org\/10.1182\/blood-2018-03-838540","journal-title":"Blood"},{"issue":"6","key":"331_CR53","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ni925","volume":"4","author":"P Liu","year":"2003","unstructured":"Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA, Copeland NG (2003) Bcl11a is essential for normal lymphoid development. Nat Immunol 4(6):525\u2013532","journal-title":"Nat Immunol"},{"issue":"2","key":"331_CR54","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","volume":"173","author":"N Liu","year":"2018","unstructured":"Liu N, Hargreaves VV, Zhu Q, Kurland JV, Hong J, Kim W, Sher F, Macias-Trevino C, Rogers JM, Kurita R (2018) Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch. Cell 173(2):430\u2013442. e417","journal-title":"Cell"},{"key":"331_CR55","first-page":"1739","volume":"122","author":"K Lobner","year":"2013","unstructured":"Lobner K, Lanzkron S, Haywood C (2013) NIH and National Foundation Expenditures for sickle cell disease and cystic fibrosis are associated with Pubmed publications and FDA approvals. Blood 122:1739","journal-title":"Blood"},{"key":"331_CR56","doi-asserted-by":"publisher","unstructured":"Lomova A, Clark DN, Campo-Fernandez B, Flores-Bjurstr\u00f6m C, Kaufman ML, Fitz-Gibbon S, Wang X, Miyahira EY, Brown D, DeWitt MA (2018) Improving gene editing outcomes in human hematopoietic stem and progenitor cells by temporal control of DNA repair. Stem Cells:1\u201311. https:\/\/doi.org\/10.1002\/stem.2935","DOI":"10.1002\/stem.2935"},{"issue":"4","key":"331_CR57","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2174\/15665232113139990026","volume":"13","author":"A M Scharenberg","year":"2013","unstructured":"M Scharenberg A, Duchateau P, Smith J (2013) Genome engineering with TAL-effector nucleases and alternative modular nuclease technologies. Curr Gene Ther 13(4):291\u2013303","journal-title":"Curr Gene Ther"},{"key":"331_CR58","doi-asserted-by":"publisher","unstructured":"Magis W, DeWitt MA, Wyman SK, Vu JT, Heo S-J, Shao SJ, Hennig F, Romero ZG, Campo-Fernandez B, McNeill M (2018) In vivo selection for corrected \u03b2-globin alleles after CRISPR\/Cas9 editing in human sickle hematopoietic stem cells enhances therapeutic potential. BioRxiv:432716. https:\/\/doi.org\/10.1101\/432716","DOI":"10.1101\/432716"},{"key":"331_CR59","doi-asserted-by":"publisher","unstructured":"Martin R, Ikeda K, Uchida N, Cromer MK, Nishimura T, Dever DP, Camarena J, Bak R, Lausten A, Jakobsen MR (2018) Selection-free, high frequency genome editing by homologous recombination of human pluripotent stem cells using Cas9 RNP and AAV6. BioRxiv:252163. https:\/\/doi.org\/10.1101\/252163","DOI":"10.1101\/252163"},{"issue":"4","key":"331_CR60","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41588-018-0085-0","volume":"50","author":"GE Martyn","year":"2018","unstructured":"Martyn GE, Wienert B, Yang L, Shah M, Norton LJ, Burdach J, Kurita R, Nakamura Y, Pearson RC, Funnell AP (2018) Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding. Nat Genet 50(4):498\u2013503","journal-title":"Nat Genet"},{"issue":"6270","key":"331_CR61","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1126\/science.aad3312","volume":"351","author":"T Masuda","year":"2016","unstructured":"Masuda T, Wang X, Maeda M, Canver MC, Sher F, Funnell AP, Fisher C, Suciu M, Martyn GE, Norton LJ (2016) Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. Science 351(6270):285\u2013289","journal-title":"Science"},{"issue":"10","key":"331_CR62","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ng2108","volume":"39","author":"S Menzel","year":"2007","unstructured":"Menzel S, Garner C, Gut I, Matsuda F, Yamaguchi M, Heath S, Foglio M, Zelenika D, Boland A, Rooks H (2007) A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet 39(10):1197\u20131199","journal-title":"Nat Genet"},{"issue":"7","key":"331_CR63","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nbt.3245","volume":"33","author":"Y Nihongaki","year":"2015","unstructured":"Nihongaki Y, Kawano F, Nakajima T, Sato M (2015) Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat Biotechnol 33(7):755\u2013760","journal-title":"Nat Biotechnol"},{"issue":"6408","key":"331_CR64","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1126\/science.aas9129","volume":"361","author":"H Nishimasu","year":"2018","unstructured":"Nishimasu H, Shi X, Ishiguro S, Gao L, Hirano S, Okazaki S, Noda T, Abudayyeh OO, Gootenberg JS, Mori H (2018) Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361(6408):1259\u20131262","journal-title":"Science"},{"issue":"2","key":"331_CR65","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bjh.15021","volume":"180","author":"A Paikari","year":"2018","unstructured":"Paikari A, Sheehan VA (2018) Fetal haemoglobin induction in sickle cell disease. Br J Haematol 180(2):189\u2013200","journal-title":"Br J Haematol"},{"issue":"4","key":"331_CR66","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.stemcr.2016.12.017","volume":"8","author":"S Park","year":"2017","unstructured":"Park S, Gianotti-Sommer A, Molina-Estevez FJ, Vanuytsel K, Skvir N, Leung A, Rozelle SS, Shaikho EM, Weir I, Jiang Z (2017) A comprehensive, ethnically diverse library of sickle cell disease-specific induced Pluripotent stem cells. Stem Cell Rep 8(4):1076\u20131085","journal-title":"Stem Cell Rep"},{"issue":"9","key":"331_CR67","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.2673","volume":"31","author":"V Pattanayak","year":"2013","unstructured":"Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR (2013) High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol 31(9):839\u2013843","journal-title":"Nat Biotechnol"},{"issue":"2","key":"331_CR68","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/003335491613100221","volume":"131","author":"ST Paulukonis","year":"2016","unstructured":"Paulukonis ST, Eckman JR, Snyder AB, Hagar W, Feuchtbaum LB, Zhou M, Grant AM, Hulihan MM (2016) Defining sickle cell disease mortality using a population-based surveillance system, 2004 through 2008. Public Health Rep 131(2):367\u2013375","journal-title":"Public Health Rep"},{"issue":"7","key":"331_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN (2013) Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med 10(7):e1001484","journal-title":"PLoS Med"},{"key":"331_CR70","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.omtm.2018.08.003","volume":"10","author":"N Psatha","year":"2018","unstructured":"Psatha N, Reik A, Phelps S, Zhou Y, Dalas D, Yannaki E, Levasseur DN, Urnov FD, Holmes MC, Papayannopoulou T (2018) Disruption of the BCL11A erythroid enhancer reactivates fetal hemoglobin in erythroid cells of patients with \u03b2-thalassemia major. Mol Ther Methods Clin Dev 10:313\u2013326","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"51","key":"331_CR71","doi-asserted-by":"crossref","first-page":"E7110","DOI":"10.1073\/pnas.1520883112","volume":"112","author":"M Rahdar","year":"2015","unstructured":"Rahdar M, McMahon MA, Prakash TP, Swayze EE, Bennett CF, Cleveland DW (2015) Synthetic CRISPR RNA-Cas9\u2013guided genome editing in human cells. Proc Natl Acad Sci 112(51):E7110\u2013E7117","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"331_CR72","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Lin C-Y, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154(6):1380\u20131389","journal-title":"Cell"},{"issue":"7546","key":"331_CR73","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, Zetsche B, Shalem O, Wu X, Makarova KS (2015) In vivo genome editing using Staphylococcus aureus Cas9. Nature 520(7546):186\u2013191","journal-title":"Nature"},{"key":"331_CR74","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fgene.2018.00240","volume":"9","author":"B Roy","year":"2018","unstructured":"Roy B, Zhao J, Yang C, Luo W, Xiong T, Li Y, Fang X, Gao G, Singh CO, Madsen L (2018) CRISPR\/cascade 9-mediated genome editing-challenges and opportunities. Front Genet 9:240\u2013252","journal-title":"Front Genet"},{"issue":"7","key":"331_CR75","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.bbmt.2015.03.007","volume":"21","author":"C Saenz","year":"2015","unstructured":"Saenz C, Tisdale JF (2015) Assessing costs, benefits, and risks in chronic disease: taking the long view. Biol Blood Marrow Transplant 21(7):1149\u20131150","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"331_CR76","doi-asserted-by":"publisher","first-page":"a011643","DOI":"10.1101\/cshperspect.a011643","volume":"3","author":"VG Sankaran","year":"2013","unstructured":"Sankaran VG, Orkin SH (2013) The switch from fetal to adult hemoglobin. Cold Spring Harb Perspect Med 3(1):a011643","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"6","key":"331_CR77","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/aps.2017.2","volume":"38","author":"G Shim","year":"2017","unstructured":"Shim G, Kim D, Park GT, Jin H, Suh S-K, Oh Y-K (2017) Therapeutic gene editing: delivery and regulatory perspectives. Acta Pharmacol Sin 38(6):738\u2013753","journal-title":"Acta Pharmacol Sin"},{"key":"331_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15464","volume":"8","author":"HY Shin","year":"2017","unstructured":"Shin HY, Wang C, Lee HK, Yoo KH, Zeng X, Kuhns T, Yang CM, Mohr T, Liu C, Hennighausen L (2017) CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat Commun 8:15464","journal-title":"Nat Commun"},{"key":"331_CR79","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","volume":"10","author":"VL Simhadri","year":"2018","unstructured":"Simhadri VL, McGill J, McMahon S, Wang J, Jiang H, Sauna ZE (2018) Prevalence of pre-existing antibodies to CRISPR-associated nuclease Cas9 in the US population. Mol Ther Methods Clin Dev 10:105\u2013112","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"6268","key":"331_CR80","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aad5227","volume":"351","author":"IM Slaymaker","year":"2016","unstructured":"Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F (2016) Rationally engineered Cas9 nucleases with improved specificity. Science 351(6268):84\u201388","journal-title":"Science"},{"issue":"5","key":"331_CR81","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1542\/peds.2005-1611","volume":"117","author":"LA Smith","year":"2006","unstructured":"Smith LA, Oyeku SO, Homer C, Zuckerman B (2006) Sickle cell disease: a question of equity and quality. Pediatrics 117(5):1763\u20131770","journal-title":"Pediatrics"},{"issue":"19","key":"331_CR82","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1182\/blood-2016-08-736249","volume":"128","author":"EC Smith","year":"2016","unstructured":"Smith EC, Luc S, Croney DM, Woodworth MB, Greig LC, Fujiwara Y, Nguyen M, Sher F, Macklis JD, Bauer DE (2016) Strict in vivo specificity of the Bcl11a erythroid enhancer. Blood 128(19):2338\u20132342. https:\/\/doi.org\/10.1182\/blood-2016-08-736249","journal-title":"Blood"},{"issue":"5","key":"331_CR83","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1182\/blood.V46.5.683.bloodjournal465683","volume":"46","author":"G Stamatoyannopoulos","year":"1975","unstructured":"Stamatoyannopoulos G, Wood W, Papayannopoulou T, Nute P (1975) A new form of hereditary persistence of fetal hemoglobin in blacks and its association with sickle cell trait. Blood 46(5):683\u2013692","journal-title":"Blood"},{"issue":"13","key":"331_CR84","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","volume":"289","author":"MH Steinberg","year":"2003","unstructured":"Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA 289(13):1645\u20131651","journal-title":"JAMA"},{"issue":"1","key":"331_CR85","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.str.2010.12.003","volume":"19","author":"BL Stoddard","year":"2011","unstructured":"Stoddard BL (2011) Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure 19(1):7\u201315","journal-title":"Structure"},{"issue":"7655","key":"331_CR86","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nature22370","volume":"545","author":"R Sugimura","year":"2017","unstructured":"Sugimura R, Jha DK, Han A, Soria-Valles C, da Rocha EL, Lu Y-F, Goettel JA, Serrao E, Rowe RG, Malleshaiah M (2017) Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature 545(7655):432\u2013438","journal-title":"Nature"},{"issue":"9","key":"331_CR87","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00439-016-1688-0","volume":"135","author":"I Tasan","year":"2016","unstructured":"Tasan I, Jain S, Zhao H (2016) Use of genome-editing tools to treat sickle cell disease. Hum Genet 135(9):1011\u20131028","journal-title":"Hum Genet"},{"issue":"6","key":"331_CR88","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nbt.2908","volume":"32","author":"SQ Tsai","year":"2014","unstructured":"Tsai SQ, Wyvekens N, Khayter C, Foden JA, Thapar V, Reyon D, Goodwin MJ, Aryee MJ, Joung JK (2014) Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32(6):569\u2013576","journal-title":"Nat Biotechnol"},{"issue":"2","key":"331_CR89","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33(2):187\u2013197","journal-title":"Nat Biotechnol"},{"issue":"1","key":"331_CR90","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13059-015-0739-5","volume":"16","author":"JC Tsang","year":"2015","unstructured":"Tsang JC, Yu Y, Burke S, Buettner F, Wang C, Kolodziejczyk AA, Teichmann SA, Lu L, Liu P (2015) Single-cell transcriptomic reconstruction reveals cell cycle and multi-lineage differentiation defects in Bcl11a-deficient hematopoietic stem cells. Genome Biol 16(1):178","journal-title":"Genome Biol"},{"issue":"5","key":"331_CR91","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1073\/pnas.0711566105","volume":"105","author":"M Uda","year":"2008","unstructured":"Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, Usala G, Busonero F, Maschio A, Albai G (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of \u03b2-thalassemia. Proc Natl Acad Sci 105(5):1620\u20131625","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"331_CR92","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrg2842","volume":"11","author":"FD Urnov","year":"2010","unstructured":"Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11(9):636\u2013646","journal-title":"Nat Rev Genet"},{"issue":"8","key":"331_CR93","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","volume":"24","author":"CA Vakulskas","year":"2018","unstructured":"Vakulskas CA, Dever DP, Rettig GR, Turk R, Jacobi AM, Collingwood MA, Bode NM, McNeill MS, Yan S, Camarena J (2018) A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells. Nat Med 24(8):1216\u20131224","journal-title":"Nat Med"},{"issue":"6","key":"331_CR94","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJM199608083350601","volume":"335","author":"MC Walters","year":"1996","unstructured":"Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K, Bernaudin F, Matthews DC (1996) Bone marrow transplantation for sickle cell disease. N Engl J Med 335(6):369\u2013376","journal-title":"N Engl J Med"},{"issue":"12","key":"331_CR95","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1053\/bbmt.2001.v7.pm11787529","volume":"7","author":"M Walters","year":"2001","unstructured":"Walters M, Patience M, Leisenring W, Rogers Z, Aquino V, Buchanan G, Roberts I, Yeager A, Hsu L, Adamkiewicz T (2001) Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant 7(12):665\u2013673","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"331_CR96","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41588-018-0094-z","volume":"50","author":"X Wang","year":"2018","unstructured":"Wang X, Thein SL (2018) Switching from fetal to adult hemoglobin. Nat Genet 50(4):478\u2013480","journal-title":"Nat Genet"},{"issue":"9778","key":"331_CR97","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","volume":"377","author":"WC Wang","year":"2011","unstructured":"Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 377(9778):1663\u20131672","journal-title":"Lancet"},{"issue":"26","key":"331_CR98","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1182\/blood-2009-Blood","volume":"115","author":"RE Ware","year":"2010","unstructured":"Ware RE (2010) How I use hydroxyurea to treat young patients with sickle cell anemia. Blood 115(26):5300\u20135311. https:\/\/doi.org\/10.1182\/blood-2009-Blood","journal-title":"Blood"},{"issue":"6","key":"331_CR99","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/00006254-194812000-00022","volume":"3","author":"J Watson","year":"1948","unstructured":"Watson J, Stahman AW, Bilello FP (1948) The significance of the paucity of sickle cells in newborn Negro infants. Obstet Gynecol Surv 3(6):819\u2013820","journal-title":"Obstet Gynecol Surv"},{"issue":"1","key":"331_CR100","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13045-017-0489-9","volume":"10","author":"J Wen","year":"2017","unstructured":"Wen J, Tao W, Hao S, Zu Y (2017) Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing. J Hematol Oncol 10(1):119","journal-title":"J Hematol Oncol"},{"issue":"7385","key":"331_CR101","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nature10886","volume":"482","author":"B Wiedenheft","year":"2012","unstructured":"Wiedenheft B, Sternberg SH, Doudna JA (2012) RNA-guided genetic silencing systems in bacteria and archaea. Nature 482(7385):331\u2013338","journal-title":"Nature"},{"issue":"8","key":"331_CR102","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg3763","volume":"15","author":"H Yin","year":"2014","unstructured":"Yin H, Kanasty RL, Eltoukhy AA, Vegas AJ, Dorkin JR, Anderson DG (2014) Non-viral vectors for gene-based therapy. Nat Rev Genet 15(8):541\u2013555","journal-title":"Nat Rev Genet"},{"issue":"2","key":"331_CR103","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nbt.3149","volume":"33","author":"B Zetsche","year":"2015","unstructured":"Zetsche B, Volz SE, Zhang F (2015) A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotechnol 33(2):139\u2013142","journal-title":"Nat Biotechnol"},{"issue":"3","key":"331_CR104","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1182\/blood-2006-11-057893","volume":"110","author":"SA Zimmerman","year":"2007","unstructured":"Zimmerman SA, Schultz WH, Burgett S, Mortier NA, Ware RE (2007) Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood 110(3):1043\u20131047","journal-title":"Blood"}],"container-title":["Advances in Experimental Medicine and Biology","Cell Biology and Translational Medicine, Volume 5"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2018_331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T06:55:35Z","timestamp":1606373735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2018_331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030175887","9783030175894"],"references-count":104,"URL":"https:\/\/doi.org\/10.1007\/5584_2018_331","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"5 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}